The AAFP recognizes that all family physicians should be alert to physical and behavioral signs and symptoms associated with abuse or neglect. The AAFP concludes that the evidence is insufficient to recommend for or against screening of parents or guardians for the physical abuse or neglect of children, of adults or adolescents of either sex for intimate partner violence, or of older adults or their caregivers for elder abuse.
Clinical Considerations: www.ahrq.gov/clinic/uspstf/uspsfamv.htm
F-J: Recommendations for Clinical Preventive Services
Family Violence and Intimate Partner Violence
Genital Herpes Simplex Virus Infection
The AAFP recommends against routine serological screening for herpes simplex virus (HSV) in asymptomatic pregnant women at any time during pregnancy to prevent neonatal HSV infection.
Clinical Considerations: www.ahrq.gov/clinic/uspstf05/herpes/herpesrs.htm#clinical
Clinical Considerations: www.ahrq.gov/clinic/uspstf05/herpes/herpesrs.htm#clinical
Genital Herpes Simplex Virus Infection
The AAFP recommends against routine serological screening for herpes simplex virus (HSV) in asymptomatic adolescents and adults.
Clinical Considerations: www.ahrq.gov/clinic/uspstf05/herpes/herpesrs.htm#clinical
Clinical Considerations: www.ahrq.gov/clinic/uspstf05/herpes/herpesrs.htm#clinical
Glaucoma
The AAFP found insufficient evidence to recommend for or against screening adults for glaucoma.
Clinical Considerations: www.ahrq.gov/clinic/uspstf05/glaucoma/glaucrs.htm#clinical
Clinical Considerations: www.ahrq.gov/clinic/uspstf05/glaucoma/glaucrs.htm#clinical
Gonococcal Infection in Neonates
The AAFP strongly recommends prophylactic ocular topical medication for all newborns against gonococcal ophthalmia neonatorum.
Clinical Consideration: www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm#clinical
Clinical Consideration: www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm#clinical
Gonorrhea
The AAFP recommends that clinicians screen all sexually active women, including those who are pregnant, for gonorrhea infection if they are at increased risk for infection (that is, if they are young or have other individual or population risk factors); see clinical consideration for further discussion of risk factors.
Clinical Consideration: www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm#clinical
Clinical Consideration: www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm#clinical
Gonorrhea
The AAFP concludes there is insufficient evidence to recommend for or against routine screening for gonorrhea infection in men at increased risk for infection; see clinical consideration for further discussion of risk factors.
Clinical Consideration: www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm#clinical
Clinical Consideration: www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm#clinical
Gonorrhea
The AAFP concludes there is insufficient evidence to recommend for or against screening for gonorrhea infection in pregnant women who are not at increased risk for infection; see clinical consideration for further discussion of risk factors.
Clinical Consideration: www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm#clinical
Clinical Consideration: www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm#clinical
Gonorrhea
The AAFP recommends against routine screening for gonorrhea infection in men and women who are at low risk for infection; see clinical consideration for further discussion of risk factors.
Clinical Consideration: www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm#clinical
Clinical Consideration: www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm#clinical
H. Influenza type b disease
The AAFP strongly recommends immunizing all children for H. Influenza type b disease using AAFP recommendations unless contraindicated.
Recommended Childhood and Adolescent Immunization Schedule
Recommended Childhood and Adolescent Immunization Schedule
Healthy Diet
The AAFP recommends intensive behavioral dietary counseling for adult patients with hyperlipidemia and other known risk factors for cardiovascular and diet-related chronic disease. Intensive counseling can be delivered by primary care physicians or by other qualified professionals including dietitians and nutritionists.
Clinical Considerations: www.ahrq.gov/clinic/3rduspstf/diet/dietrr.htm#clinical
Clinical Considerations: www.ahrq.gov/clinic/3rduspstf/diet/dietrr.htm#clinical
Hearing difficulties
The AAFP recommends screening for hearing difficulties by questioning elderly adults about hearing impairment and counsel regarding the availability of treatment when appropriate.
Clinical Considerations: www.ahrq.gov/clinic/uspstf/uspshear.htm
Clinical Considerations: www.ahrq.gov/clinic/uspstf/uspshear.htm
Hearing Loss Sensorineural (SNHL)
The AAFP concludes that there is insufficient evidence on which to make a recommendation for or against routine screening of newborns for hearing loss during the postpartum hospitalization period.
Clinical Consideration: www.ahrq.gov/clinic/3rduspstf/newbornscreen/newhearrr.htm#section2
Clinical Consideration: www.ahrq.gov/clinic/3rduspstf/newbornscreen/newhearrr.htm#section2
Hemochromatosis
The AAFP recommends against routine genetic screening for hereditary hemochromatosis in the asymptomatic general population.
Clinical Considerations: www.ahrq.gov/uspstf06/hemochromatosis/hemochrs.htm#clinical
Clinical Considerations: www.ahrq.gov/uspstf06/hemochromatosis/hemochrs.htm#clinical
Hemoglobinopathies
The AAFP strongly recommends ordering screening tests for PKU, hemoglobinopathies, and thyroid function abnormalities in neonates.
Clinical Consideration: www.ahrq.gov/clinic/uspstf/uspshemo.htm
Clinical Consideration: www.ahrq.gov/clinic/uspstf/uspshemo.htm
Hepatitis A
The AAFP recommends immunizing adults for hepatitis A who live, work or travel in areas where Hepatitis A is endemic and periodic and periodic outbreaks occur, or users of injection or street drugs, military personnel, men who have sex with men, and institutionalized persons and those working in those institutions.
Recommended Adult Immunization Schedule
Recommended Adult Immunization Schedule
Hepatitis A
The AAFP strongly recommends immunizing children for Hepatitis A who are more than 2 years of age and all adolescents who are living in, traveling to, or working in areas where hepatitis A is endemic and periodic outbreaks occur. Immunize using AAFP recommendations.
Recommended Childhood and Adolescent Immunization Schedule
Recommended Childhood and Adolescent Immunization Schedule
Hepatitis B
The AAFP strongly recommends immunizing infants and children who are unimmunized at age 11-12 for Hepatitis B using AAFP recommendations.
Recommended Childhood and Adolescent Immunization Schedule
Recommended Childhood and Adolescent Immunization Schedule
Hepatitis B
The AAFP strongly recommends immunizing persons for Hepatitis B who are injection drug users and their sexual partners, have a history of multiple sexual partners in a pervious 6 months, have recently acquired a sexually transmitted disease, recipients of certain drug products, have a health related job with frequent exposure to blood or blood products, travelers to countries where HBV is of high or intermediate endemicity, or who are men who have sex with men. Complete primary series.
Recommended Adult Immunization Schedule
Recommended Adult Immunization Schedule
Hepatitis B
The AAFP recommends immunizing for hepatitis B unimmunized person’s age 12-24 years with no reliable history of hepatitis B infection or previous immunization. Discuss immunization using AAFP recommendations.
Recommended Childhood and Adolescent Immunization Schedule
Recommended Childhood and Adolescent Immunization Schedule
Hepatitis B Virus Infection
The AAFP strongly recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit.
Clinical Consideration: www.ahrq.gov/clinic/uspstf/uspshepb.htm
Clinical Consideration: www.ahrq.gov/clinic/uspstf/uspshepb.htm
Hepatitis B Virus Infection
The AAFP recommends against routinely screening the general asymptomatic population for chronic hepatitis B virus infection.
Clinical Consideration: www.ahrq.gov/clinic/uspstf/uspshepb.htm
Clinical Consideration: www.ahrq.gov/clinic/uspstf/uspshepb.htm
Hepatitis C
The AAFP recommends against routine screening for hepatitis C virus (HCV) infection in asymptomatic adults who are not at increased risk (general population) for infection.
Clinical Consideration: www.ahrq.gov/clinic/uspstf/uspshepc.htm
Clinical Consideration: www.ahrq.gov/clinic/uspstf/uspshepc.htm
Hepatitis C Virus Infection
The AAFP found insufficient evidence to recommend for or against routine screening for hepatitis C virus (HCV) infection in adults at high risk for infection.
Clinical Consideration: www.ahrq.gov/clinic/uspstf/uspshepc.htm
Clinical Consideration: www.ahrq.gov/clinic/uspstf/uspshepc.htm
High Blood Pressure
The AAFP strongly recommends screening for high blood pressure in adults aged 18 and older.
Clinical Consideration: www.ahrq.gov/clinic/uspstf07/hbp/hbprs.htm#clinical
Clinical Consideration: www.ahrq.gov/clinic/uspstf07/hbp/hbprs.htm#clinical
HIV Infection
The AAFP strongly recommends that physicians screen for human immunodeficiency virus (HIV) all adolescents and adults at increased risk for HIV infection.
Go to Clinical Considerations for discussion of risk factors:
http://www.ahrq.gov/clinic/uspstf05/hiv/hivrs.htm#clinical
Also See: HIV Policy Statement (August 2006)
Go to Clinical Considerations for discussion of risk factors:
http://www.ahrq.gov/clinic/uspstf05/hiv/hivrs.htm#clinical
Also See: HIV Policy Statement (August 2006)
HIV Infection
The AAFP recommends that clinicians screen all pregnant women for HIV.
Go to Clinical Considerations for discussion of risk factors:
http://www.ahrq.gov/clinic/uspstf05/hiv/hivrs.htm#clinical
Also See: HIV Policy Statement (August 2006)
Go to Clinical Considerations for discussion of risk factors:
http://www.ahrq.gov/clinic/uspstf05/hiv/hivrs.htm#clinical
Also See: HIV Policy Statement (August 2006)
HIV Infection
The AAFP makes no recommendation for or against routinely screening for HIV in adolescents and adults who are not at increased risk for HIV infection.
Go to Clinical Considerations for discussion of risk factors:
http://www.ahrq.gov/clinic/uspstf05/hiv/hivrs.htm#clinical
Also See: HIV Policy Statement (August 2006)
Go to Clinical Considerations for discussion of risk factors:
http://www.ahrq.gov/clinic/uspstf05/hiv/hivrs.htm#clinical
Also See: HIV Policy Statement (August 2006)
Hormone Replacement Therapy
The AAFP recommends against the routine use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women.
Clinical Considerations: www.ahrq.gov/clinic/uspstf05/ht/htpostmenrs.htm#clinical
Clinical Considerations: www.ahrq.gov/clinic/uspstf05/ht/htpostmenrs.htm#clinical
Hormone Replacement Therapy
The AAFP recommends against the routine use of unopposed estrogen for the prevention of chronic conditions in postmenopausal women who have had a hysterectomy.
Clinical Considerations: www.ahrq.gov/clinic/uspstf05/ht/htpostmenrs.htm#clinical
Clinical Considerations: www.ahrq.gov/clinic/uspstf05/ht/htpostmenrs.htm#clinical
Hypertension
The AAFP concludes that the evidence is insufficient to recommend for or against routine screening for high blood pressure in children and adolescents to reduce the risk of cardiovascular disease.
Clinical Considerations: www.ahrq.gov/clinic/uspstf/uspshype.htm
Clinical Considerations: www.ahrq.gov/clinic/uspstf/uspshype.htm
Idiopathic Scoliosis in Adolescents
The AAFP recommends against the routine screening of asymptomatic adolescents for idiopathic scoliosis.
Clinical Considerations: http://www.ahrq.gov/clinic/uspstf/uspsaisc.htm
Clinical Considerations: http://www.ahrq.gov/clinic/uspstf/uspsaisc.htm
Influenza
The AAFP recommends immunizing children and adolescents age 6 months or older for influenza who are residents of chronic care facilities, or who have chronic cardiopulmonary disorders, metabolic disease including diabetes mellitus, hemoglobinopathies, immunosuppression, or renal dysfunction for influenza. Discuss immunizing annually using AAFP recommendations.
Recommended Childhood and Adolescent Immunization Schedule
Recommended Childhood and Adolescent Immunization Schedule
Influenza
The AAFP recommends immunizing adults for influenza who are residents of chronic care facilities, or suffer from chronic cardiopulmonary disorders, metabolic disease (including diabetes mellitus), hemoglobinopathies, immunosuppression, renal dysfunction, or are health care providers for the above. Discuss immunization annually using AAFP recommendations.
Recommended Adult Immunization Schedule
Recommended Adult Immunization Schedule
Influenza
The AAFP recommends immunizing adults for influenza who are residents of chronic care facilities, or suffer from chronic cardiopulmonary disorders, metabolic disease (including diabetes mellitus), hemoglobinopathies, immunosuppression, renal dysfunction, or are health care providers for the above. Discuss immunization annually using AAFP recommendations.
Recommended Adult Immunization Schedule
Recommended Adult Immunization Schedule
Insulin Dependent Diabetes Mellitus
The AAFP recommends against the use of immune marker screening for insulin dependent diabetes mellitus in asymptomatic persons.
Iron Deficiency Anemia
The AAFP recommends routine screening for iron deficiency anemia in asymptomatic pregnant women.
Clinical Considerations: www.ahrq.gov/clinic/uspstf06/ironsc/ironrs.htm#clinical
Clinical Considerations: www.ahrq.gov/clinic/uspstf06/ironsc/ironrs.htm#clinical
Iron Deficiency Anemia
The AAFP concludes that the evidence is insufficient to recommend for or against routine screening for iron deficiency anemia in asymptomatic children aged 6 to 12 months.
Clinical Considerations: www.ahrq.gov/clinic/uspstf06/ironsc/ironrs.htm#clinical
Clinical Considerations: www.ahrq.gov/clinic/uspstf06/ironsc/ironrs.htm#clinical
Clinical Preventive Services
AAFP Summary of Recommendations for Clinical Preventive Services Tool
F-J
Clinical Preventive Services (*PDF file)
(*PDF file. About PDFs)
